TXNIP contributes to HIV-1 transcriptional competence and inducible reactivation through an EZH2-ETV1 regulatory pathway
Persistent human immunodeficiency virus type 1 (HIV-1) latency remains a major barrier to durable remission, yet the host pathways that regulate proviral transcriptional competence and inducible reactivation remain incompletely defined. Thioredoxin-interacting protein (TXNIP) is a glucose-responsive host factor, but its role in HIV-1 transcription and latency regulation has not been established. Here, we provide evidence that TXNIP supports HIV-1 long terminal repeat (LTR)-driven transcription, productive replication, and latency reversal. Genetic depletion of TXNIP reduced LTR reporter activity, nascent viral transcripts, virus production, and latency-reversing agent (LRA)-induced reactivation across reporter-based, productive-infection, chronically infected, latency, primary-cell, and ex vivo models, whereas TXNIP overexpression enhanced viral transcriptional output. Chromatin immunoprecipitation (ChIP) further detected TXNIP-associated signals at HIV-1 LTR-containing chromatin in both TZM-bl and Jurkat T-cell contexts, and co-immunoprecipitation (Co-IP) analyses showed that TXNIP associates with BRD4-, CDK9-, and Tat-containing transcriptional complexes, consistent with a cofactor-associated model of TXNIP-linked HIV-1 transcriptional regulation. Mechanistically, our data support an enhancer of zeste homolog 2 (EZH2)-ETS variant transcription factor 1 (ETV1)-TXNIP regulatory axis linking epigenetic repression to HIV-1 transcriptional control. Genetic EZH2 perturbation and pharmacological perturbation of EZH2-associated repression reduced histone H3 lysine 27 trimethylation (H3K27me3) enrichment at the ETV1 promoter, increased ETV1 expression, and enhanced TXNIP promoter activity. ChIP-qPCR and promoter-reporter analyses supported an ETV1-associated regulatory link between EZH2-associated repression and TXNIP expression. Pharmacological perturbation with SRI-37330 suppressed HIV-1 replication, nascent transcription, and inducible reactivation, including in ex vivo CD4+ T cells from antiretroviral therapy (ART)-suppressed individuals; this inhibitory effect was attenuated in TXNIP-depleted cells. Together, these findings identify TXNIP as a host determinant of HIV-1 transcriptional competence and support an EZH2-ETV1-TXNIP regulatory pathway that links epigenetic regulation of TXNIP expression to HIV-1 transcriptional control.
Authors
- 梁泰鎭
- Muye Xia
- Shuwen Liu (ORCID: https://orcid.org/0000-0001-6346-5006)
- Lin Li (ORCID: https://orcid.org/0000-0002-2443-3121)
- Yibin Li (ORCID: https://orcid.org/0000-0001-9484-149X)
- Ziyao Wu
- Jie Peng
- Han Zhang
- Yuzai Zhang
- Chenliang Zhou
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
- Guangzhou Laboratory (CN)
- Nanchang Medical College (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- PLoS Pathogens
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1371/journal.ppat.1014748
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- National Science and Technology Major Project
- National Major Science and Technology Projects of China
- Basic and Applied Basic Research Foundation of Guangdong Province